Literature DB >> 7248998

Physical training program in arterial hypertension. A long-term prospective follow-up.

O Román, A L Camuzzi, E Villalón, C Klenner.   

Abstract

A long-term training program was performed on 30 chronic hypertensive female patients, stages I-II, WHO criteria. The effect on blood pressure (BP) and other physiological parameters, as exercise BP, heart rate, physical working capacity, VO2max, double product, were studied. Four phases were outlined throughout the trial: (1) 3 months training at 70% of the maximal heart rate; (2) 3 months without training; (3) 1 year training at the same level as phase I, and (4) 12 or more months with increasing intensity training over 70% of the maximal heart rate. Serial ergometric work tests were performed every 3 months. We observed a close relationship between physical working capacity and VO2max increases with training intensity. Resting BP fell significantly with training (182/114-161/97 mm Hg; p less than 0.001) but increased again when training was discontinued (161/97-179/115 mm Hg; p less than 0.001). BP persisted low throughout the trial, but there was a tendency to a further but not significant decrease when training intensity was raised over 70% of the maximal heart rate. Both the submaximal and maximal exercise BP showed similar changes to those found in the resting BP throughout the trial. The submaximal heart rate and the double product (BP X heart rate) also fell significantly with training but with maximal values not changing significantly throughout the whole follow-up period.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7248998     DOI: 10.1159/000173248

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  14 in total

Review 1.  Exercise and hypertension: facts and uncertainties.

Authors:  M A van Baak
Journal:  Br J Sports Med       Date:  1998-03       Impact factor: 13.800

2.  Cardiovascular effects of training for a marathon run in unfit middle aged men.

Authors:  I N Findlay; R S Taylor; H J Dargie; S Grant; A R Pettigrew; J T Wilson; T Aitchison; J G Cleland; A T Elliott; B M Fisher
Journal:  Br Med J (Clin Res Ed)       Date:  1987-08-29

Review 3.  Prehypertension: Underlying pathology and therapeutic options.

Authors:  Sulayma Albarwani; Sultan Al-Siyabi; Musbah O Tanira
Journal:  World J Cardiol       Date:  2014-08-26

4.  Physical activity and blood pressure in normotensive young women.

Authors:  E Saar; R Chayoth; N Meyerstein
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1986

5.  The disease-specific benefits and risks of physical activity and exercise.

Authors:  D S Siscovick; R E LaPorte; J M Newman
Journal:  Public Health Rep       Date:  1985 Mar-Apr       Impact factor: 2.792

Review 6.  Physical activity in older adults. An overview of health benefits.

Authors:  L S Pescatello; L DiPietro
Journal:  Sports Med       Date:  1993-06       Impact factor: 11.136

7.  Lifestyle modifications to prevent and control hypertension. 4. Recommendations on physical exercise training. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.

Authors:  J Cléroux; R D Feldman; R J Petrella
Journal:  CMAJ       Date:  1999-05-04       Impact factor: 8.262

Review 8.  Exercise and mild essential hypertension. Recommendations for adults.

Authors:  N F Gordon; C B Scott; W J Wilkinson; J J Duncan; S N Blair
Journal:  Sports Med       Date:  1990-12       Impact factor: 11.136

9.  Differential aerobic exercise-induced changes in plasma aldosterone between African Americans and Caucasians.

Authors:  Jennifer M Jones; Thomas C Dowling; Jung-Jun Park; Dana A Phares; Joon-Young Park; Thomas O Obisesan; Michael D Brown
Journal:  Exp Physiol       Date:  2007-05-04       Impact factor: 2.969

Review 10.  Physical activity in human hypertension. A mechanisms approach.

Authors:  W L Kenney; E J Zambraski
Journal:  Sports Med       Date:  1984 Nov-Dec       Impact factor: 11.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.